期刊文献+

雄激素受体反义寡核苷酸对前列腺癌细胞生长的抑制作用 被引量:6

Inhibition of prostate cancer cell proliferation by androgen receptor antisense oligodeoxynucleotides
原文传递
导出
摘要 目的 探讨雄激素受体 (AR)反义寡核苷酸 (aODN)对前列腺癌细胞AR表达和生长的抑制作用。 方法 合成 1对AR正、反义寡核苷酸 ,与LNCaP细胞共培养 ,观察LNCaP细胞的增殖情况 ,RT PCR和Westernblot方法检测ARmRNA水平和AR蛋白表达水平。 结果 含ARaODN的培养基培养处于静止期和对数生长期的LNCaP细胞增殖较对照组均明显减慢。RT PCR证实aODN组吸光度A值 (0 .5 3± 0 .18)与ODN组 (1.14± 0 .2 1)差异有显著性意义 (P <0 .0 5 ) ,提示ARaODN可导致LNCaP细胞ARmRNA显著下调。Westernblot分析显示aODN组条带的吸光度A值 (2 6 .35± 1.33)与ODN组 (33.5 1± 1.4 8)之间差异有显著性意义 (P <0 .0 5 ) ,提示ARaODN可下调LNCaP细胞AR蛋白含量。 结论 ARaODN可抑制前列腺癌细胞AR表达并抑制前列腺癌细胞增殖。 Objective To study the inhibition of AR expression and prostate cancer cell proliferation with androgen receptor(AR) antisense oligodeoxynucleotides(aODN). Methods A pair of AR sense and antisense oligodeoxynucleotides was designed and synthesized. LNCaP cells were cultured with AR ODN and AR aODN. The proliferation of the cells was observed and the AR mRNA and AR protein were detected by RT-PCR and Western blot. Results The proliferation of quiescent and logarithmic phase LNCaP cells was inhibited when cultured with AR aODN.RT-PCR showed that the optical density ratio was significantly different between the aODN group(0.53±0.18)and the ODN group(1.14±0.21), P <0.05,demonstrating that AR aODN could down-regulate the level of AR mRNA of LNCaP cells.Western blot showed that the optical density was significantly different between the aODN group(26.35±1.33)and the ODN group(33.51±1.48), P <0.05,demonstrating that AR aODN could reduce the content of AR protein of LNCaP cells. Conclusions AR aODN inhibits the proliferation of LNCaP by suppressing the AR expression.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2003年第6期383-385,共3页 Chinese Journal of Urology
基金 国家自然科学基金资助项目 (3 9770 740 )
关键词 前列腺癌 雄激素受体 反义寡核苷酸 细胞生长 Prostatic neoplasms Receptor,androgen Antisense oligodeoxynucleotide
  • 相关文献

参考文献7

  • 1J.萨姆布鲁克等著.金冬雁 等译.分子克隆实验指南:第2版[M].北京:科学技术出版社,1992.888-897.
  • 2Koivisto P, Kolmer M, Visakorpi T, et al. Androgen receptor gene and hormonal therapy failure of prostate cancer. Am J Pathol, 1998,152 : 1 -9.
  • 3Jenster G. The role of androgen receptor in the development and progression of prostate cancer. Semin Oncol, 1999,26:407-421.
  • 4Agrawal S. Antisense oligonucleotides: towards clinical trial. Trends Biotechnol, 1996,14:376-387.
  • 5Agrawal S,Zhao Q. Antisense therapeutics. Current Opin Chem Biol,1998,2:519-528.
  • 6Wagner RW, Flanagan WM. Antisense technology and prospects for therapy of viral infections and cancer. Mol Med Today, 1997,3 : 31 -38.
  • 7Galderisi U, Cascino A, Giordano A. Antisense oligonucleotides as therapeutic agents. J Cell Physil, 1999,181:251-257.

同被引文献64

  • 1张尧,江军,王洛夫.前列腺特异性启动子rPB的改造及其载体质粒的构建和活性测定[J].第三军医大学学报,2005,27(10):981-984. 被引量:4
  • 2杨军,胡新华,张志深,刘程伟,陈哲,张强.反义寡核苷酸抑制Survivin基因表达对移植静脉内膜增生的影响[J].中华实验外科杂志,2005,22(12):1516-1518. 被引量:8
  • 3王诚,鲍圣德,刘胜,陈谦学,吴涛,齐辉.基因靶向抑制反义生存素对脑胶质瘤细胞增殖和凋亡的影响[J].中华实验外科杂志,2006,23(5):557-559. 被引量:11
  • 4Schrijvers D. Androgen-independent prostate cancer[ J]. Recent Resuits Cancer Res, 2007, 175 : 239 -249.
  • 5Singh P, Uzgare A, Litvinov I, et al. Combinatorial androgen receptor targeted therapy for prostate cancer [ J]. Endocr Retat Cancer, 2006, 13(3) : 653 -666.
  • 6Iversen P L, Arora V, Acker A J, et al. Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase 1 safety study in humans[ J]. Clin Cancer Res, 2003, 9 (7) : 2510 -2519.
  • 7Essand M. Gene therapy and immunotherapy of prostate cancer: adenoviral-based strategies [ J ]. Acta Oncol, 2005, 44 ( 6 ) : 610 - 627.
  • 8Lee S J, Kim H S, Yu R, et al. Novel prostate-speeifie promoter derived from PSA and PSMA enhancers[J]. Mol Ther, 2002, 6(3) : 415 -421.
  • 9Kasper S,Cookson MS. Mechanisms leading to the development of hormone-resistant prostate cancer [ J ].Urol Clin North Am,2006,33(2) :201.
  • 10Sharifi N,Farrar WL. Androgen receptor as a therapeutic target for androgen independent prostate cancer[J]. Am J Ther,2006,13 (2) : 166.

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部